207 related articles for article (PubMed ID: 35328514)
1. A Homozygous Deep Intronic Variant Causes Von Willebrand Factor Deficiency and Lack of Endothelial-Specific Secretory Organelles, Weibel-Palade Bodies.
Yadegari H; Jamil MA; Marquardt N; Oldenburg J
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328514
[TBL] [Abstract][Full Text] [Related]
2. Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.
Haberichter SL; Merricks EP; Fahs SA; Christopherson PA; Nichols TC; Montgomery RR
Blood; 2005 Jan; 105(1):145-52. PubMed ID: 15331450
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor propeptide variants lead to impaired storage and ER retention in patient-derived endothelial colony-forming cells.
Bowman M; Casey L; Selvam SN; Lima PDA; Rawley O; Hinds M; Tuttle A; Grabell J; Iorio A; Walker I; Lillicrap D; James P
J Thromb Haemost; 2022 Jul; 20(7):1599-1609. PubMed ID: 35466528
[TBL] [Abstract][Full Text] [Related]
4. Multifaceted pathomolecular mechanism of a VWF large deletion involved in the pathogenesis of severe VWD.
Yadegari H; Jamil MA; Müller J; Marquardt N; Rawley O; Budde U; El-Maarri O; Lillicrap D; Oldenburg J
Blood Adv; 2022 Feb; 6(3):1038-1053. PubMed ID: 34861678
[TBL] [Abstract][Full Text] [Related]
5. Reduced von Willebrand factor secretion is associated with loss of Weibel-Palade body formation.
Castaman G; Giacomelli SH; Jacobi PM; Obser T; Budde U; Rodeghiero F; Schneppenheim R; Haberichter SL
J Thromb Haemost; 2012 May; 10(5):951-8. PubMed ID: 22429825
[TBL] [Abstract][Full Text] [Related]
6. Variability of von Willebrand factor-related parameters in endothelial colony forming cells.
de Jong A; Weijers E; Dirven R; de Boer S; Streur J; Eikenboom J
J Thromb Haemost; 2019 Sep; 17(9):1544-1554. PubMed ID: 31265169
[TBL] [Abstract][Full Text] [Related]
7. Clusterin knockdown has effects on intracellular and secreted von Willebrand factor in human umbilical vein endothelial cells.
Cox AA; Liu A; Ng CJ
PLoS One; 2024; 19(2):e0298133. PubMed ID: 38363768
[TBL] [Abstract][Full Text] [Related]
8. Emerging mechanisms to modulate VWF release from endothelial cells.
El-Mansi S; Nightingale TD
Int J Biochem Cell Biol; 2021 Feb; 131():105900. PubMed ID: 33301925
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand disease and Weibel-Palade bodies.
Wang JW; Eikenboom J
Hamostaseologie; 2010 Aug; 30(3):150-5. PubMed ID: 20680229
[TBL] [Abstract][Full Text] [Related]
10. Biogenesis of Weibel-Palade bodies in von Willebrand's disease variants with impaired von Willebrand factor intrachain or interchain disulfide bond formation.
Wang JW; Groeneveld DJ; Cosemans G; Dirven RJ; Valentijn KM; Voorberg J; Reitsma PH; Eikenboom J
Haematologica; 2012 Jun; 97(6):859-66. PubMed ID: 22207689
[TBL] [Abstract][Full Text] [Related]
11. Intracellular storage and regulated secretion of von Willebrand factor in quantitative von Willebrand disease.
Wang JW; Valentijn KM; de Boer HC; Dirven RJ; van Zonneveld AJ; Koster AJ; Voorberg J; Reitsma PH; Eikenboom J
J Biol Chem; 2011 Jul; 286(27):24180-8. PubMed ID: 21596755
[TBL] [Abstract][Full Text] [Related]
12. Von Willebrand factor targets IL-8 to Weibel-Palade bodies in an endothelial cell line.
Romani de Wit T; de Leeuw HP; Rondaij MG; de Laaf RT; Sellink E; Brinkman HJ; Voorberg J; van Mourik JA
Exp Cell Res; 2003 May; 286(1):67-74. PubMed ID: 12729795
[TBL] [Abstract][Full Text] [Related]
13. Weibel-Palade Body Localized Syntaxin-3 Modulates Von Willebrand Factor Secretion From Endothelial Cells.
Schillemans M; Karampini E; van den Eshof BL; Gangaev A; Hofman M; van Breevoort D; Meems H; Janssen H; Mulder AA; Jost CR; Escher JC; Adam R; Carter T; Koster AJ; van den Biggelaar M; Voorberg J; Bierings R
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1549-1561. PubMed ID: 29880488
[TBL] [Abstract][Full Text] [Related]
14. Cellular and molecular basis of von Willebrand disease: studies on blood outgrowth endothelial cells.
Starke RD; Paschalaki KE; Dyer CE; Harrison-Lavoie KJ; Cutler JA; McKinnon TA; Millar CM; Cutler DF; Laffan MA; Randi AM
Blood; 2013 Apr; 121(14):2773-84. PubMed ID: 23355534
[TBL] [Abstract][Full Text] [Related]
15. Weibel-Palade bodies: a window to von Willebrand disease.
Valentijn KM; Eikenboom J
J Thromb Haemost; 2013 Apr; 11(4):581-92. PubMed ID: 23398618
[TBL] [Abstract][Full Text] [Related]
16. A noncanonical splicing variant c.875-5 T > G in von Willebrand factor causes in-frame exon skipping and type 2A von Willebrand disease.
Liang Q; Zhang Z; Ding B; Shao Y; Ding Q; Dai J; Hu X; Wu W; Wang X
Thromb Res; 2024 Apr; 236():51-60. PubMed ID: 38387303
[TBL] [Abstract][Full Text] [Related]
17. Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease.
Gallinaro L; Sartorello F; Pontara E; Cattini MG; Bertomoro A; Bartoloni L; Pagnan A; Casonato A
Thromb Haemost; 2006 Dec; 96(6):711-6. PubMed ID: 17139363
[TBL] [Abstract][Full Text] [Related]
18. von Willebrand factor propeptide missense variants affect anterograde transport to Golgi resulting in ER retention.
Yadegari H; Biswas A; Ahmed S; Naz A; Oldenburg J
Hum Mutat; 2021 Jun; 42(6):731-744. PubMed ID: 33942438
[TBL] [Abstract][Full Text] [Related]
19. Dispatch and delivery at the ER-Golgi interface: how endothelial cells tune their hemostatic response.
Kat M; Margadant C; Voorberg J; Bierings R
FEBS J; 2022 Nov; 289(22):6863-6870. PubMed ID: 35246944
[TBL] [Abstract][Full Text] [Related]
20. Small GTP-binding protein Ral modulates regulated exocytosis of von Willebrand factor by endothelial cells.
de Leeuw HP; Fernandez-Borja M; Reits EA; Romani de Wit T; Wijers-Koster PM; Hordijk PL; Neefjes J; van Mourik JA; Voorberg J
Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):899-904. PubMed ID: 11397694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
